Literature DB >> 20665130

Prevalence and diagnosis of primary aldosteronism.

Gian Paolo Rossi1.   

Abstract

Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11.2% in consecutive referred hypertensive patients. When adrenal vein sampling (AVS) is available, two thirds of the cases can be attributed to a tumor and one third of cases are idiopathic; the opposite is seen when AVS is unavailable. Thus, AVS influences the relative prevalence rate of the main subtypes of PA. When adrenalectomy is undertaken based on AVS, almost 100% of patients are cured of hyperaldosteronism, one third are cured of hypertension, and 52% are markedly improved in terms of blood pressure control. Persistent hypertension can be predicted by a long history of hypertension and by the presence of excessive cardiovascular damage, including vascular remodeling. Therefore, an early diagnosis is crucial to achieve cure. This review discusses the implications of the high prevalence of PA for its diagnostic strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665130     DOI: 10.1007/s11906-010-0134-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

Review 1.  Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

Review 2.  Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course.

Authors:  Teresa M Seccia; Ambrogio Fassina; Gastone G Nussdorfer; Achille C Pessina; Gian Paolo Rossi
Journal:  Endocr Relat Cancer       Date:  2005-03       Impact factor: 5.678

Review 3.  Plasma renin and aldosterone measurements in low renin hypertensive states.

Authors:  Jean E Sealey; Richard D Gordon; Franco Mantero
Journal:  Trends Endocrinol Metab       Date:  2005-04       Impact factor: 12.015

Review 4.  Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.

Authors:  Gian Paolo Rossi; Teresa M Seccia; Achille C Pessina
Journal:  Crit Rev Clin Lab Sci       Date:  2007       Impact factor: 6.250

5.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

6.  Aldosterone induces a vascular inflammatory phenotype in the rat heart.

Authors:  Ricardo Rocha; Amy E Rudolph; Gregory E Frierdich; Denise A Nachowiak; Beverly K Kekec; Eric A G Blomme; Ellen G McMahon; John A Delyani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

7.  Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

Authors:  G P Rossi; A Sacchetto; E Pavan; P Palatini; G R Graniero; C Canali; A C Pessina
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

8.  High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.

Authors:  Michael Stowasser; Richard D Gordon; Thanuja G Gunasekera; Diane C Cowley; Gregory Ward; Colin Archibald; B Mark Smithers
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

9.  Relations between cardiac and vascular structure in patients with primary and secondary hypertension.

Authors:  D Rizzoni; M L Muiesan; E Porteri; M Salvetti; M Castellano; G Bettoni; G Tiberio; S M Giulini; C Monteduro; G Garavelli; E Agabiti-Rosei
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

Review 10.  Primary aldosteronism: an update on screening, diagnosis and treatment.

Authors:  Gian Paolo Rossi; Achille Cesare Pessina; Anthony M Heagerty
Journal:  J Hypertens       Date:  2008-04       Impact factor: 4.844

View more
  18 in total

Review 1.  Assessment and management of resistant hypertension.

Authors:  Raj S Padwal; Simon Rabkin; Nadia Khan
Journal:  CMAJ       Date:  2014-08-18       Impact factor: 8.262

Review 2.  This is not Dr. Conn's aldosterone anymore.

Authors:  Nancy J Brown
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

3.  Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.

Authors:  Hongliang Li; Xichun Yu; Maria Verena Cicala; Franco Mantero; Alexandria Benbrook; Vineet Veitla; Madeleine W Cunningham; David C Kem
Journal:  J Am Soc Hypertens       Date:  2014-10-23

Review 4.  Approach to the surgical management of primary aldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Donato Nitti
Journal:  Gland Surg       Date:  2015-02

5.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

6.  Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese Population.

Authors:  Lin-Ping Wang; Kun-Qi Yang; Xiong-Jing Jiang; Hai-Ying Wu; Hui-Min Zhang; Yu-Bao Zou; Lei Song; Jin Bian; Ru-Tai Hui; Ya-Xin Liu; Xian-Liang Zhou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-15       Impact factor: 3.738

Review 7.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

8.  Dissecting the Effects of Aldosterone and Hypokalemia on the Epithelial Na+ Channel and the NaCl Cotransporter.

Authors:  Mathias Kristensen; Robert A Fenton; Søren B Poulsen
Journal:  Front Physiol       Date:  2022-04-26       Impact factor: 4.755

9.  The Association between Glomerular Hyperfiltration and Left Ventricular Structure and Function in Patients with Primary Aldosteronism.

Authors:  Min-Tsun Liao; Xue-Ming Wu; Chin-Chen Chang; Che-Wei Liao; Ying-Hsien Chen; Ching-Chu Lu; Yen-Ting Lin; Yi-Yao Chang; Chi-Sheng Hung; Lung-Chun Lin; Chao-Lun Lai; Lian-Yu Lin; Vin-Cent Wu; Yi-Lwun Ho; Kwan-Dun Wu; Yen-Hung Lin
Journal:  Int J Med Sci       Date:  2015-05-03       Impact factor: 3.738

10.  Reversible heart rhythm complexity impairment in patients with primary aldosteronism.

Authors:  Yen-Hung Lin; Vin-Cent Wu; Men-Tzung Lo; Xue-Ming Wu; Chi-Sheng Hung; Kwan-Dun Wu; Chen Lin; Yi-Lwun Ho; Michael Stowasser; Chung-Kang Peng
Journal:  Sci Rep       Date:  2015-08-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.